President Donald Trump on Tuesday signed an executive order that aims to delay Medicare negotiations for a broad category of prescription drugs, handing the deep-pocketed pharmaceutical industry a major win as it lobbies aggressively against efforts to rein in its pricing power. Trump’s order, titled “Lowering Drug Prices by Once Again Putting Americans First,” instructs Health and Human…